Verastem Oncology (VSTM) Misses Q3 EPS by 54c
Get Alerts VSTM Hot Sheet
Join SI Premium – FREE
Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.54). Revenue for the quarter came in at $11.24 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere conference call: 2027 orders up mid-single digits from last year)
- ScanSource (SCSC) Tops Q4 EPS by 32c
- Walmart shares fall despite earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share